Linde PLC (LIN) stock
LINNasdaqIndustrial Inorganic ChemicalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 14/3026% above fair value
$522.49−4.06 (-0.77%)
Close on Nov 12, 2026Market cap $239.87BP/E 34.7Yield 1.15%
Linde r&d expenses
Research and development expenses are spending on new products and technology.
Linde's R&D Expenses for the twelve months ending Sep 30, 2026 was $147.00M, down 2.6% year over year. For fiscal 2025 it was $147.00M, down 2.0% from the year before. The highest annual figure on record is $184.00M in fiscal 2019.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $147.00M | -2.0% |
| FY2024 | Dec 31, 2024 | $150.00M | +2.7% |
| FY2023 | Dec 31, 2023 | $146.00M | +2.1% |
| FY2022 | Dec 31, 2022 | $143.00M | 0.0% |
| FY2021 | Dec 31, 2021 | $143.00M | -5.9% |
| FY2020 | Dec 31, 2020 | $152.00M | -17.4% |
| FY2019 | Dec 31, 2019 | $184.00M | +62.8% |
| FY2018 | Dec 31, 2018 | $113.00M | +21.5% |
| FY2017 | Dec 31, 2017 | $93.00M | +1.1% |
| FY2016 | Dec 31, 2016 | $92.00M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $37.00M | +2.8% |
| Q2 FY2026 | Jun 30, 2026 | $37.00M | -2.6% |
| Q1 FY2026 | Mar 31, 2026 | $38.00M | 0.0% |
| Q4 FY2025 | Dec 31, 2025 | $35.00M | -10.3% |
| Q3 FY2025 | Sep 30, 2025 | $36.00M | -2.7% |
| Q2 FY2025 | Jun 30, 2025 | $38.00M | +5.6% |
| Q1 FY2025 | Mar 31, 2025 | $38.00M | 0.0% |
| Q4 FY2024 | Dec 31, 2024 | $39.00M | 0.0% |
| Q3 FY2024 | Sep 30, 2024 | $37.00M | +2.8% |
| Q2 FY2024 | Jun 30, 2024 | $36.00M | +2.9% |
| Q1 FY2024 | Mar 31, 2024 | $38.00M | +5.6% |
| Q4 FY2023 | Dec 31, 2023 | $39.00M | +8.3% |
| Q3 FY2023 | Sep 30, 2023 | $36.00M | +2.9% |
| Q2 FY2023 | Jun 30, 2023 | $35.00M | -5.4% |
| Q1 FY2023 | Mar 31, 2023 | $36.00M | +2.9% |
| Q4 FY2022 | Dec 31, 2022 | $36.00M | -5.3% |
| Q3 FY2022 | Sep 30, 2022 | $35.00M | -2.8% |
| Q2 FY2022 | Jun 30, 2022 | $37.00M | +8.8% |
| Q1 FY2022 | Mar 31, 2022 | $35.00M | 0.0% |
| Q4 FY2021 | Dec 31, 2021 | $38.00M | 0.0% |
| Q3 FY2021 | Sep 30, 2021 | $36.00M | 0.0% |
| Q2 FY2021 | Jun 30, 2021 | $34.00M | 0.0% |
| Q1 FY2021 | Mar 31, 2021 | $35.00M | -20.5% |
| Q4 FY2020 | Dec 31, 2020 | $38.00M | -22.4% |
| Q3 FY2020 | Sep 30, 2020 | $36.00M | -18.2% |
| Q2 FY2020 | Jun 30, 2020 | $34.00M | -24.4% |
| Q1 FY2020 | Mar 31, 2020 | $44.00M | -4.3% |
| Q4 FY2019 | Dec 31, 2019 | $49.00M | +16.7% |
| Q3 FY2019 | Sep 30, 2019 | $44.00M | +91.3% |
| Q2 FY2019 | Jun 30, 2019 | $45.00M | +87.5% |
| Q1 FY2019 | Mar 31, 2019 | $46.00M | +91.7% |
| Q4 FY2018 | Dec 31, 2018 | $42.00M | – |
| Q3 FY2018 | Sep 30, 2018 | $23.00M | – |
| Q2 FY2018 | Jun 30, 2018 | $24.00M | – |
| Q1 FY2018 | Mar 31, 2018 | $24.00M | – |
See a number that looks wrong?